Black Diamond Therapeutics Statistics Share Statistics Black Diamond Therapeutics has 56.94M
shares outstanding. The number of shares has increased by 0.63%
in one year.
Shares Outstanding 56.94M Shares Change (YoY) 0.63% Shares Change (QoQ) 0.35% Owned by Institutions (%) 71.92% Shares Floating 43.34M Failed to Deliver (FTD) Shares 4 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 7.03M, so 12.34% of the outstanding
shares have been sold short.
Short Interest 7.03M Short % of Shares Out 12.34% Short % of Float 17.72% Short Ratio (days to cover) 10.48
Valuation Ratios The PE ratio is -1.69 and the forward
PE ratio is -4.01.
Black Diamond Therapeutics's PEG ratio is
0.05.
PE Ratio -1.69 Forward PE -4.01 PS Ratio 0 Forward PS 47.5 PB Ratio 1.41 P/FCF Ratio -1.89 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Black Diamond Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.92,
with a Debt / Equity ratio of 0.27.
Current Ratio 4.92 Quick Ratio 4.92 Debt / Equity 0.27 Debt / EBITDA -0.32 Debt / FCF -0.36 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.9M Employee Count 24 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -47.5% in the
last 52 weeks. The beta is 2.94, so Black Diamond Therapeutics's
price volatility has been higher than the market average.
Beta 2.94 52-Week Price Change -47.5% 50-Day Moving Average 2.84 200-Day Moving Average 2.27 Relative Strength Index (RSI) 63.35 Average Volume (20 Days) 1,008,946
Income Statement
Revenue n/a Gross Profit -343K Operating Income -78.78M Net Income -69.68M EBITDA -69.33M EBIT -69.68M Earnings Per Share (EPS) -1.27
Full Income Statement Balance Sheet The company has 36.44M in cash and 22.19M in
debt, giving a net cash position of 14.25M.
Cash & Cash Equivalents 36.44M Total Debt 22.19M Net Cash 14.25M Retained Earnings -487.11M Total Assets 166.38M Working Capital 129.92M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -62.3M
and capital expenditures 0, giving a free cash flow of -62.3M.
Operating Cash Flow -62.3M Capital Expenditures n/a Free Cash Flow -62.3M FCF Per Share -1.13
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
